Journal of the Neurological Sciences 1993: Vol 115 Index

7 Pages·1993·1.4 MB·English

Journal of the Neurological Sciences, 115 (1993) 236-238
Elsevier Science Publishers B.V.
Author Index (V ol. 115)
Amaducci, L., see Pantoni, L. (115) 125 Gabreéls, F.J.M., see Hageman, A.T.M. (115) 95
Arendt, G., Hefter, H., Nelles, H.-W., Hilperath, F. and Strohmeyer, Garam, T., see Bokor, M. (115) 47
G. Giordano, G.P., see Pantoni, L. (115) 125
Age-dependent decline in cognitive information processing of Goldstein, M.E., see Henken, D.B. (115) 177
HIV-positive individuals detected by event-related potential Goto, I., see Kira, J.-i. (115) 111
recordings (115) 223 Goto, I., see Otsuka, M. (115) 153
Goto, S., see Matsumoto, S. (115) 208
Bertini, E., see Manfredi, G. (115) 91 Goto, Y.-i., see Sakuta, R. (115) 158
Bhattacharya, S.K., see Johnson, P.L. (115) 76 Grahmann, F., Claus, D., Grehl, H. and Neund6rfer, B.
Bokor, M., Farag6, A., Garam, T., Malatinszky, G. and Schnabel, R. Electrophysiologic evidence for a toxic polyneuropathy in rats
Antibody-dependent cell-mediated cytotoxicity (ADCC) in after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
Parkinson’s disease (115) 47 (115) 71
Boon, J.M., see Hageman, A.T.M. (115) 95 Grehl, H., see Grahmann, F. (115) 71
Bracco, L., see Pantoni, L. (115) 125
Bradley, W.G., see Robison, S.H. (115) 201 Hageman, A.T.M., Gabreéls, F.J.M., Liem, K.D., Renkawek, K. and
Brooks, D.J. Boon, J.M.
Functional imaging in relation to parkinsonian syndromes (115) 1 Congenital myotonic dystrophy; a report on thirteen cases and a
review of the literature (115) 95
Canziani, G.A., see De Lustig, E.S. (115) 18 Hashizume, Y., see Matsumoto, S. (115) 208
Carter, G., see Polihronis, M. (115) 230 Hatazawa, J., see Nagasawa, H. (115) 136
Catania, S., see Ciardi, M. (115) 117 Hefter, H., see Arendt, G. (115) 223
Catz, I., see Warren, K.G. (115) 169 Henken, D.B., Goldstein, M.E. and Martin, J.R.
Ciardi, M., Sharief, M.K., Noori, M.A., Thompson, E.J., Salotti, A., Herpes simplex virus type-2 infection by a footpad route results
Rossi, F., Vullo, V., Catania, S., Sorice, F. and Cirelli, A. in neuronal death in mouse spinal ganglia (115) 177
Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in Higuchi, I., Nakamura, K., Nakagawa, M., Nakamura, N., Usuki, F.,
asymptomatic HIV-1 seropositive individuals. Correlation with Inose, M. and Osame, M.
local production of specific IgM and IgG antibodies (115) 117 Steroid-responsive myalgia in a patient with Becker muscular
Cigin-Sain, L. and Jenner, P. dystrophy (115) 219
Reduction in cortical 5-HT, binding sites following a unilateral Hill, T.J., see Love, S. (115) 144
6-hydroxydopamine lesion of the medial forebrain bundle in rats Hilperath, F., see Arendt, G. (115) 223
(115) 105 Hirano, A., see Matsumoto, S. (115) 208
Cirelli, A., see Ciardi, M. (115) 117 Horai, S., see Sakuta, R. (115) 158
Claus, D., see Grahmann, F. (115) 71 Hosokawa, S., see Otsuka, M. (115) 153
Cohen, R.A., Kessler, H.R. and Fischer, M.
The extended disability status scale (EDSS) as a predictor of Ichinose, K., see Nagasato, K. (115) 161
impairments of functional activities of daily living in multiple Ichiya, Y., see Kira, J.-i. (115) 111
sclerosis (115) 132 Ichiya, Y., see Otsuka, M. (115) 153
Ido, T., see Nagasawa, H. (115) 136
De Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G.A., Famulari, Imai, T., see Matsumoto, S. (115) 208
A.L. and Dominguez, R.O. Inose, M., see Higuchi, I. (115) 219
Copper-zinc superoxide dismutase activity in red blood cells and Inzitari, D., see Pantoni, L. (115) 125
serum in demented patients and in aging (115) 18 Itoh, M., see Nagasawa, H. (115) 136
Dominguez, R.O., see De Lustig, E.S. (115) 18 Iwata, R., see Nagasawa, H. (115) 136
Dotti, M.T., see Federico, A. (115) 67
Jenner, P., see Ciéin-Sain, L. (115) 105
Emrich, D., see Nau, R. (115) 102 Jinno, Y., see Tamura, T. (115) 214
Johnson, P.L. and Bhattacharya, S.K.
Famulari, A.L., see De Lustig, E.S. (115) 18 Regulation of membrane-mediated chronic muscle degeneration
Farag6, A., see Bokor, M. (115) 47 in dystrophic hamsters by calcium-channel blockers: diltiazem,
Federico, A., Dotti, M.T., Loré, F. and Nuti, R. nifedipine and verapamil (115) 76
Cerebrotendinous xanthomatosis: pathophysiological study on
bone metabolism (115) 67 Kato, M., see Otsuka, M. (115) 153
Fischer, M., see Cohen, R.A. (115) 132 Kennedy, W.R. and Wendelschafer-Crabb, G.
Fujiwara, T., see Nagasawa, H. (115) 136 The innervation of human epidermis (115) 184
Fukumura, T., see Otsuka, M. (115) 153 Kessler, H.R., see Cohen, R.A. (115) 132
Journal of the Neurological Sciences, 115 (1993) 236-238
Elsevier Science Publishers B.V.
Author Index (V ol. 115)
Amaducci, L., see Pantoni, L. (115) 125 Gabreéls, F.J.M., see Hageman, A.T.M. (115) 95
Arendt, G., Hefter, H., Nelles, H.-W., Hilperath, F. and Strohmeyer, Garam, T., see Bokor, M. (115) 47
G. Giordano, G.P., see Pantoni, L. (115) 125
Age-dependent decline in cognitive information processing of Goldstein, M.E., see Henken, D.B. (115) 177
HIV-positive individuals detected by event-related potential Goto, I., see Kira, J.-i. (115) 111
recordings (115) 223 Goto, I., see Otsuka, M. (115) 153
Goto, S., see Matsumoto, S. (115) 208
Bertini, E., see Manfredi, G. (115) 91 Goto, Y.-i., see Sakuta, R. (115) 158
Bhattacharya, S.K., see Johnson, P.L. (115) 76 Grahmann, F., Claus, D., Grehl, H. and Neund6rfer, B.
Bokor, M., Farag6, A., Garam, T., Malatinszky, G. and Schnabel, R. Electrophysiologic evidence for a toxic polyneuropathy in rats
Antibody-dependent cell-mediated cytotoxicity (ADCC) in after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
Parkinson’s disease (115) 47 (115) 71
Boon, J.M., see Hageman, A.T.M. (115) 95 Grehl, H., see Grahmann, F. (115) 71
Bracco, L., see Pantoni, L. (115) 125
Bradley, W.G., see Robison, S.H. (115) 201 Hageman, A.T.M., Gabreéls, F.J.M., Liem, K.D., Renkawek, K. and
Brooks, D.J. Boon, J.M.
Functional imaging in relation to parkinsonian syndromes (115) 1 Congenital myotonic dystrophy; a report on thirteen cases and a
review of the literature (115) 95
Canziani, G.A., see De Lustig, E.S. (115) 18 Hashizume, Y., see Matsumoto, S. (115) 208
Carter, G., see Polihronis, M. (115) 230 Hatazawa, J., see Nagasawa, H. (115) 136
Catania, S., see Ciardi, M. (115) 117 Hefter, H., see Arendt, G. (115) 223
Catz, I., see Warren, K.G. (115) 169 Henken, D.B., Goldstein, M.E. and Martin, J.R.
Ciardi, M., Sharief, M.K., Noori, M.A., Thompson, E.J., Salotti, A., Herpes simplex virus type-2 infection by a footpad route results
Rossi, F., Vullo, V., Catania, S., Sorice, F. and Cirelli, A. in neuronal death in mouse spinal ganglia (115) 177
Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in Higuchi, I., Nakamura, K., Nakagawa, M., Nakamura, N., Usuki, F.,
asymptomatic HIV-1 seropositive individuals. Correlation with Inose, M. and Osame, M.
local production of specific IgM and IgG antibodies (115) 117 Steroid-responsive myalgia in a patient with Becker muscular
Cigin-Sain, L. and Jenner, P. dystrophy (115) 219
Reduction in cortical 5-HT, binding sites following a unilateral Hill, T.J., see Love, S. (115) 144
6-hydroxydopamine lesion of the medial forebrain bundle in rats Hilperath, F., see Arendt, G. (115) 223
(115) 105 Hirano, A., see Matsumoto, S. (115) 208
Cirelli, A., see Ciardi, M. (115) 117 Horai, S., see Sakuta, R. (115) 158
Claus, D., see Grahmann, F. (115) 71 Hosokawa, S., see Otsuka, M. (115) 153
Cohen, R.A., Kessler, H.R. and Fischer, M.
The extended disability status scale (EDSS) as a predictor of Ichinose, K., see Nagasato, K. (115) 161
impairments of functional activities of daily living in multiple Ichiya, Y., see Kira, J.-i. (115) 111
sclerosis (115) 132 Ichiya, Y., see Otsuka, M. (115) 153
Ido, T., see Nagasawa, H. (115) 136
De Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G.A., Famulari, Imai, T., see Matsumoto, S. (115) 208
A.L. and Dominguez, R.O. Inose, M., see Higuchi, I. (115) 219
Copper-zinc superoxide dismutase activity in red blood cells and Inzitari, D., see Pantoni, L. (115) 125
serum in demented patients and in aging (115) 18 Itoh, M., see Nagasawa, H. (115) 136
Dominguez, R.O., see De Lustig, E.S. (115) 18 Iwata, R., see Nagasawa, H. (115) 136
Dotti, M.T., see Federico, A. (115) 67
Jenner, P., see Ciéin-Sain, L. (115) 105
Emrich, D., see Nau, R. (115) 102 Jinno, Y., see Tamura, T. (115) 214
Johnson, P.L. and Bhattacharya, S.K.
Famulari, A.L., see De Lustig, E.S. (115) 18 Regulation of membrane-mediated chronic muscle degeneration
Farag6, A., see Bokor, M. (115) 47 in dystrophic hamsters by calcium-channel blockers: diltiazem,
Federico, A., Dotti, M.T., Loré, F. and Nuti, R. nifedipine and verapamil (115) 76
Cerebrotendinous xanthomatosis: pathophysiological study on
bone metabolism (115) 67 Kato, M., see Otsuka, M. (115) 153
Fischer, M., see Cohen, R.A. (115) 132 Kennedy, W.R. and Wendelschafer-Crabb, G.
Fujiwara, T., see Nagasawa, H. (115) 136 The innervation of human epidermis (115) 184
Fukumura, T., see Otsuka, M. (115) 153 Kessler, H.R., see Cohen, R.A. (115) 132
Kihira, T., Mizusawa, H., Tada, J., Namikawa, T., Yoshida, S. and Neundorfer, B., see Grahmann, F. (115) 71
Yase, Y. Niikawa, N., see Tamura, T. (115) 214
Lewy body-like inclusions in Onuf’s nucleus from two cases of Nishiura, Y., see Nagasato, K. (115) 161
sporadic amyotrophic lateral sclerosis (115) 51 Nonaka, I., see Sakuta, R. (115) 158
Kikkawa, R., see Terada, M. (115) 58 Noori, M.A., see Ciardi, M. (115) 117
Kira, J.-i., Goto, I., Otsuka, M. and Ichiya, Y. Nuti, R., see Federico, A. (115) 67
Chronic progressive spinocerebellar syndrome associated with
antibodies to human T-lymphotropic virus type I: clinico-virologi- Ohishi, K., see Nagasato, K. (115) 161
cal and magnetic resonance imaging studies (115) 111 Okazaki, H., see Matsumoto, S. (115) 208
Kogure, K., see Nagasawa, H. (115) 136 Osame, M., see Higuchi, I. (115) 219
Kohan, S., see De Lustig, E.S. (115) 18 Otsuka, M., Ichiya, Y., Kuwabara, Y., Hosokawa, S., Sasaki, M.,
Kooijman, S., see Praamstra, P. (115) 32 Fukumura, T., Masuda, K., Goto, I. and Kato, M.
Koyama, N., see Terada, M. (115) 58 Cerebral glucose metabolism and striatal ''F-Dopa uptake by
Kusaka, H., see Matsumoto, S. (115) 208 PET in cases of chorea with or without dementia (115) 153
Kuwabara, Y., see Otsuka, M. (115) 153 Otsuka, M., see Kira, J.-i. (115) 111
Liem, K.D., see Hageman, A.T.M. (115) 95 Pagel, C.N., see Morgan, J.E. (115) 191
Lolli, F., see Pantoni, L. (115) 125 Paizis, K., see Polihronis, M. (115) 230
Loré, F., see Federico, A. (115) 67 Pantoni, L., Inzitari, D., Pracucci, G., Lolli, F., Giordano, G.P.,
Love, S., Hill, T.J. and Maitland, N.J. Bracco, L. and Amaducci, L.
Cerebrospinal fluid proteins in patients with leucoaraiosis: possi-
MS strain of type 2 herpes simplex virus produces necrotizing
retinitis in mice (115) 144 ble abnormalities in blood-brain barrier function (115) 125
Papacci, M., see Manfredi, G. (115) 91
Partridge, T.A., see Morgan, J.E. (115) 191
Maitland, N.J., see Love, S. (115) 144
Polihronis, M., Paizis, K., Carter, G., Sedal, L. and Murphy, B.
Malatinszky, G., see Bokor, M. (115) 47
Elevation of human cerebrospinal fluid clusterin concentration is
Manfredi, G., Silvestri, G., Servidei, S., Ricci, E., Mirabella, M.,
associated with acute neuropathology (115) 230
Bertini, E., Papacci, M., Rana, M. and Tonali, P.
Praamstra, P., Stegeman, D.F., Kooijman, S. and Moleman, J.
Manifesting heterozygotes in McArdle’s disease: clinical, morpho-
Evoked potential measures of auditory cortical function and
logical and biochemical studies in a family (115) 91
auditory comprehension in aphasia (115) 32
Martin, J.R., see Henken, D.B. (115) 177
Pracucci, G., see Pantoni, L. (115) 125
Masuda, K., see Otsuka, M. (115) 153
Prange, H.W., see Nau, R. (115) 102
Matsumoto, S., Goto, S., Kusaka, H., Imai, T., Murakami, N.,
Hashizume, Y., Okazaki, H. and Hirano, A.
Rana, M., see Manfredi, G. (115) 91
Ubiquitin-positive inclusion in anterior horn cells in subgroups of
Renkawek, K., see Hageman, A.T.M. (115) 95
motor neuron diseases: a comparative study of adult-onset amy-
Ricci, E., see Manfredi, G. (115) 91
otrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis
Robison, S.H., Tandan, R. and Bradley, W.G.
and Werdnig-Hoffmann disease (115) 208
Repair of N-methylpurines in DNA from lymphocytes of patients
Miike, T., see Tamura, T. (115) 214
with amyotrophic lateral sclerosis (115) 201
Mirabella, M., see Manfredi, G. (115) 91
Rossi, F., see Ciardi, M. (115) 117
Mizusawa, H., see Kihira, T. (115) 51
Moleman, J., see Praamstra, P. (115) 32 Saito, H., see Nagasawa, H. (115) 136
Morgan, J.E., Pagel, C.N., Sherrratt, T. and Partridge, T.A. Sakuta, R., Goto, Y.-i., Horai, S. and Nonaka, I.
Long-term persistence and migration of myogenic cells injected Mitochondrial DNA mutations at nucleotide positions 3243 and
into pre-irradiated muscles of mdx mice (115) 191 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis,
Murakami, N., see Matsumoto, S. (115) 208 and stroke-like episodes: a comparative study (115) 158
Murphy, B., see Polihronis, M. (115) 230 Salotti, A., see Ciardi, M. (115) 117
Sasaki, M., see Otsuka, M. (115) 153
Nagasato, K., Nakamura, T., Ichinose, K., Nishiura, Y., Ohishi, K., Schnabel, R., see Bokor, M. (115) 47
Shibayama, K., Watanabe, H., Tsujihata, M. and Nagataki, S. Schwartz, P.H. and Wasterlain, C.G.
Heparin treatment in patients with human T-lymphotropic virus Determination of serum and brain concentrations of neuropro-
type I (HTLV-I)-associated myelopathy: a preliminary study (115) tective and non-neuroprotective doses of MK-801 (115) 26
161 Sedal, L., see Polihronis, M. (115) 230
Nagasawa, H., Saito, H., Kogure, K., Hatazawa, J., Itoh, M., Fuji- Seo, S., see Nagasawa, H. (115) 136
wara, T., Watanuki, S., Seo, S., Iwata, R. and Ido, T. Serra, J.A., see De Lustig, E.S. (115) 18
6-[!8F]Fluorodopa metabolism in patients with hemiparkinsonism Servidei, S., see Manfredi, G. (115) 91
studied by positron emission tomography (115) 136 Sharief, M.K., see Ciardi, M. (115) 117
Nagataki, S., see Nagasato, K. (115) 161 Sherrratt, T., see Morgan, J.E. (115) 191
Nakagawa, M., see Higuchi, I. (115) 219 Shibayama, K., see Nagasato, K. (115) 161
Nakamura, K., see Higuchi, I. (115) 219 Shigeta, Y., see Terada, M. (115) 58
Nakamura, N., see Higuchi, I. (115) 219 Silvestri, G., see Manfredi, G. (115) 91
Nakamura, T., see Nagasato, K. (115) 161 Sorice, F., see Ciardi, M. (115) 117
Namikawa, T., see Kihira, T. (115) 51 Stegeman, D.F., see Praamstra, P. (115) 32
Nau, R., Emrich, D. and Prange, H.W. Strohmeyer, G., see Arendt, G. (115) 223
Inverse correlation between disappearance of intrathecally in-
jected '''In-DTPA from CSF with CSF protein content and Tada, J., see Kihira, T. (115) 51
CSF-to-serum albumin ratio (115) 102 Tamura, T., Yoshioka, K., Jinno, Y., Niikawa, N. and Miike, T.
Nelles, H.-W., see Arendt, G. (115) 223 Dystrophin isoforms expressed in the mouse retina (115) 214
238
Tandan, R., see Robison, S.H. (115) 201 Warren, K.G. and Catz, I.
Terada, M., Yasuda, H., Kikkawa, R., Koyama, N., Yokota, T. and Autoantibodies to myelin basic protein within multiple sclerosis
Shigeta, Y. central nervous system tissue (115) 169
Electrophysiological study of dorsal column function in strepto- Wasterlain, C.G., see Schwartz, P.H. (115) 26
zocin-induced diabetic rats: comparison with 2,5-hexanedione Watanabe, H., see Nagasato, K. (115) 161
intoxication (115) 58 Watanuki, S., see Nagasawa, H. (115) 136
Thompson, E.J., see Ciardi, M. (115) 117 Wendelschafer-Crabb, G., see Kennedy, W.R. (115) 184
Tonali, P., see Manfredi, G. (115) 91
Tsujihata, M., see Nagasato, K. (115) 161 Yase, Y., see Kihira, T. (115) 51
Yasuda, H., see Terada, M. (115) 58
Usuki, F., see Higuchi, I. (115) 219 Yokota, T., see Terada, M. (115) 58
Yoshida, S., see Kihira, T. (115) 51
Vullo, V., see Ciardi, M. (115) 117 Yoshioka, K., see Tamura, T. (115) 214
Journal of the Neurological Sciences, 115 (1993) 239-240
Elsevier Science Publishers B.V.
Subject Index (Vol. 115)
Activation, (115) 1 Duchenne muscular dystrophy, (115) 76
ADL, (115) 132 Dystrophin, (115) 191, (115) 214
Aging, (115) 18
AIDS, (115) 117 EDSS, (115) 132
Aldolase, (115) 76 Epidermis, (115) 184
Alkaline elution, (115) 201 Event-related potential, (115) 223
Alzheimer’s disease, (115) 18 Evoked potential, (115) 58
Amyotrophic lateral sclerosis, (115) 201 Excessive intracellular calcium accumulation, (115) 76
Amyotrophic lateral sclerosis: Juvenile amyotrophic lateral sclerosis,
(115) 208 Fasciculus gracile, (115) 58
Analytical chemistry, (115) 26 6-[!8F]Fluorodopa, (115) 136
Anterior horn cell, (115) 208
Antibody-dependent cell-mediated cytotoxicity (ADCC), (115) 47 Gas chromatography, (115) 26
Anti-HIV-1 antibody, (115) 117 Glucose metabolism, (115) 153
Antioxidant enzyme, (115) 18 Glycogenosis type 5, (115) 91
Aphasia, (115) 32
Auditory comprehension, (115) 32 Hemichorea, (115) 153
Auditory cortical function, (115) 32 Hemiparkinsonism, (115) 136
Auditory evoked potentials, (115) 32 Heparin, (115) 161
Heredity, (115) 95
Becker muscular dystrophy, (115) 219 Herpes simplex virus type-2, (115) 144; (115) 177
Blood-brain barrier, (115) 125 2,5-Hexanedione, (115) 58
Blood-CSF barrier, (115) 102 Histopathology, (115) 76
Blood flow, (115) 1 HIV-1, (115) 117
Bone metabolism, (115) 67 HIV infection, (115) 223
Brain, (115) 214 HSV-2, (115) 177
HTLV-I, (115) 111
Cardiomyopathy, (315) 219 HTLV-I-associated myelopathy, (115) 111, (115) 161
Cell migration, (115) 191 5-HT; receptors, (115) 105
Central nervous system, (115) 169 Huntington’s disease, (115) 153
Cerebral ischemia, (115) 26 6-Hydroxydopamine, (115) 105
Cerebrospinal fluid, (115) 102, (115) 117, (115) 125 Hypertrophic cardiomyopathy, (115) 76
Cerebrotendinous xanthomatosis, (115) 67 Hypotonia, (115) 95
Chorea, (115) 153
Choreoacanthocytosis, (115) 153 IgG, (115) 117
Clusterin, (115) 230 IgM, (115) 117
Complement, (115) 230 Immunohistochemistry, (115) 184
Congenital, (115) 95 ‘ll Indium-diethylenetriamine pentaacetic acid, (115) 102
Creatine kinase, (115) 76 Interleukin-2, (115) 117
CSF, (115) 230
CSF protein content, (115) 102 Killer cell, (115) 47
CSF-to-serum albumin ratio, (115) 102
Cytotoxic capacity test, (115) 47 Lactate dehydrogenase, (115) 76
Leucoaraiosis, (115) 125
Dementia, (115) 153 Leukoencephalopathy, (115) 111
Deoxyribonucleic acid repair, (115) 201 Lewy body-like inclusion, (115) 51
Diabetic myelopathy, (115) 58 Lymphocyte, (115) 201
Dihydrofolate reductase gene, (115) 201
Dioxin neurotoxicity, (115) 71 Magnetic resonance imaging (MRI), (115) 111
Dipole source analysis, (115) 32 Manifesting heterozygote, (115) 91
Disability, (115) 132 anti-MBP, (115) 169
Dizocilpine, (115) 26 McArdle’s disease, (115) 91
Dopamine, (115) 1, (115) 105 max, (115) 191
'8SE_Dopa uptake, (115) 153 MELAS, (115) 158
Dorsal root ganglia, (115) 177 Mental retardation, (115) 219
DRG, (115) 177 Metabolism, (115) 1
240
Methyl! methanesulfonate, (115) 201 Reduced mortality rate, (115) 76
N-Methylpurine, (115) 201 Relative soleus hypertrophy, (115) 76
Microcirculation, (115) 161 Residual activity, (115) 91
Mitochondrial DNA (muscle), (115) 158 Retina, (115) 214
Mitochondrial myopathy, (115) 158 Retinitis, (115) 144
Motor nerve conduction velocity, (115) 58 Reverse PCR, (115) 214
Mouse, (115) 214
Multiple sclerosis, (115) 132, (115) 169 Scintigraphy, (115) 102
Muscle, (115) 214 Sensory ganglia, (115) 177
Muscle phosphorylase, (115) 91 Sensory nerve conduction velocity, (115) 58
Muscle precursor cell, (115) 191 Sensory receptor, (115) 184
Mutation, 3243 and 3271, (115) 158 Serotonin, (115) 105
Myalgia, (115) 219 Single photon emission tomography, (115) 1
Myoblast transfer, (115) 191 Skein-like inclusion, (115) 51
Myotonic dystrophy, (115) 95 Slowing of cognitive processes, (115) 223
Spinocerebellar degeneration, (115) 111
Nerve, (115) 184 Spontaneous lymphocyte proliferation, (115) 161
Neuroimmunology, (115) 47 Sporadic amyotrophic lateral sclerosis, (115) 51
Neuronal death, (115) 177 Steroid therapy, (115) 219
Neuropathology, (115) 95 Streptozocin, (115) 58
Non-specific cell-mediated immunity, (115) 47 Superoxide dismutase, (115) 18
O, free radical, (115) 18
T-cell trafficking, (115) 161
Onuf’s nucleus, (115) 51 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), (115) 71
Optic nerve, (115) 144 Tissue distribution, (115) 26
Osteoporosis, (115) 67 Toxic polyneuropathy in rats, (115) 71
Trigeminal ganglia, (115) 144
Parkinson’s disease, (115) 1, (115) 47
Tropical spastic paraparesis, (115) 111
Pharmacokinetics, (115) 26
Positron emission tomography, (115) 1, (115) 136, (115) 153 Ubiquitin, (115) 208
Protein gene product (PGP) 9.5, (115) 184
Pupillary reflex, (115) 144
Vascular dementia, (115) 18, (115) 125
Rat brain, (115) 105
Receptors, (115) 1 Werdnig-Hoffmann disease, (115) 208
ae.’